Dr Bradley Ray Wenderoth, PHARMD | |
1500 San Pablo St, Los Angeles, CA 90033 | |
(323) 865-9974 | |
Not Available |
Full Name | Dr Bradley Ray Wenderoth |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 1500 San Pablo St, Los Angeles, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114340379 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 66409 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Bradley Ray Wenderoth, PHARMD 14006 Otsego St, Sherman Oaks, CA 91423-1225 Ph: () - | Dr Bradley Ray Wenderoth, PHARMD 1500 San Pablo St, Los Angeles, CA 90033 Ph: (323) 865-9974 |
News Archive
Self-affirmation, the practice of reflecting upon one's most important values, can aid Black medical students in reaching their residency goals. But conversely, it can lead to the perception that they are less qualified for a prestigious residency than their peers.
GEA Niro has selected engineering simulation software from ANSYS to optimize equipment design and reduce development time and costs. Based in Denmark, GEA Niro is a world market leader in drying technology for the dairy, food, pharmaceutical and chemical industries and is a core technology center in the GEA Process Engineering business segment in GEA Group.
OraSure Technologies, the market leader in oral fluid diagnostics, announced today that Quest Diagnostics Incorporated released new data indicating that oral fluid revealed approximately five times more heroin use in the general U.S. workforce than previously believed.
Scientific American examines the interface between climate change and human health, writing, "WHO research suggests that current warming of global average temperatures of just under one degree Celsius is responsible for an additional 150,000 deaths per year, largely due to agricultural failures and diarrheal disease in developing countries.
Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, today announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, (131)I-CLR1404 has been completed. Results of this trial will be used to set the starting dose in a follow-on Phase I dose escalation study planned for later this year. Institutions that participated in the trial include City of Hope, Duke University Medical Center, Georgetown University/Lombardi Cancer Center, and Johns Hopkins Hospital.
› Verified 9 days ago
Robert W Cheung, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3550 S La Brea Ave, Los Angeles, CA 90016 Phone: 323-293-9397 | |
Mrs. Afaf Guirguis Karanany, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4044 Eagle Rock Blvd, Los Angeles, CA 90065 Phone: 323-254-8642 | |
Dr. Stephanie Mary Liang Luo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 San Pablo St, Los Angeles, CA 90089 Phone: 213-486-8652 | |
Mr. Benjamin S Kaster, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11340 Iowa Ave Apt 8, Los Angeles, CA 90025 Phone: 310-478-6179 Fax: 310-478-6179 | |
Sarah Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11321 National Blvd, Los Angeles, CA 90064 Phone: 310-479-5729 | |
Linda Han, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6041 Cadillac Ave, Kaiser West Los Angeles Medical Center, Los Angeles, CA 90034 Phone: 323-857-3989 | |
Dr. John Ball, PHARMACIST (PHARMD) Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3400 Whittier Blvd, Los Angeles, CA 90023 Phone: 562-773-3285 Fax: 323-268-1940 |